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Abstract
Background: Surgical samples have long been used as important subjects for cancer research. In accordance with an
increase of neoadjuvant therapy, biopsy samples have recently become imperative for cancer transcriptome. On the other
hand, both biopsy and surgical samples are available for expression profiling for predicting clinical outcome by adjuvant
therapy; however, it is still unclear whether surgical sample expression profiles are useful for prediction via biopsy samples,
because little has been done about comparative gene expression profiling between the two kinds of samples.
Methodology and Findings: A total of 166 samples (77 biopsy and 89 surgical) of normal and malignant lesions of the
esophagus were analyzed by microarrays. Gene expression profiles were compared between biopsy and surgical samples.
Artificially induced epithelial-mesenchymal transition (aiEMT) was found in the surgical samples, and also occurred in mouse
esophageal epithelial cell layers under an ischemic condition. Identification of clinically significant subgroups was thought
to be disrupted by the disorder of the expression profile through this aiEMT.
Conclusion and Significance: This study will evoke the fundamental misinterpretation including underestimation of the
prognostic evaluation power of markers by overestimation of EMT in past cancer research, and will furnish some advice for
the near future as follows: 1) Understanding how long the tissues were under an ischemic condition. 2) Prevalence of biopsy
samples for in vivo expression profiling with low biases on basic and clinical research. 3) Checking cancer cell contents and
normal- or necrotic-tissue contamination in biopsy samples for prevalence.
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Introduction
Cancer is a major cause of human deaths in many countries.
Gene expression profiles from DNA microarrays are individual-
ized and useful in the diagnosis and prognosis of diseases [1].
Although some artificial factors such as ischemia, hypoxia,
hyponutrition, and cold stress possibly occur during surgical
resection and sample transportation (Figure S1), surgical samples
have long been used as important subjects for clinical and basic
cancer research. In accordance with an increase of neoadjuvant
therapy (in head and neck, esophageal, lung, pancreatic, prostate,
and breast cancers), biopsy samples have recently become
imperative for cancer transcriptome. On the other hand, both
biopsy and surgical samples are available for expression profiling
for predicting clinical outcome by adjuvant therapy (in stomach,
colon, liver, bladder, pancreatic, brain, kidney, ovarian, cervical,
and breast cancers). The targets for microarray analysis were, for
the last ten years, mostly surgical samplesfrom the development
and prevalence of two types of microarray: oligonucleotide [2, 3]
and cDNA [4, 5]. However, whether a huge number of
accumulated surgical sample expression profiles are useful for
prediction by the use of biopsy samples from pretreated patients is
still unclear, because little has been done about comparative gene
expression profiling between the two kinds of samples.
Chemoradiotherapy (CRT) followed by surgery is the standard
therapy for esophageal cancer in Western countries. In Japan,
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18196neoadjuvant chemotherapy followed by surgery and definitive
CRT are the standard therapies [6], and for locally advanced
esophageal cancers (Stage II or III), surgery was the standard
therapy there approximately 5 years ago [7]. This enables us to
obtain both biopsy and surgical samples from esophageal cancer
patients and to compare gene expression profiles between these
two kinds of samples. Here we report that artificially induced
epithelial-mesenchymal transition (aiEMT) occurs in surgical
samples. Its presence there has possibly interfered not only with
microarray- or immunohistochemistory-based clinical research but
also with basic research.
Results
Comparison of Expression Profiles between Biopsy and
Surgically Resected Esophageal Tumor Samples Obtained
from Different Cases
We first compared gene expression profiles between 35 fresh
biopsy samples containing no necrotic lesion and 66 surgical
esophageal tumor samples, which were obtained from a margin of
the tumor after exposure for 4–7 hours under an ischemic
condition, by unsupervised clustering with 3,126 processed genes
(Materials and Methods). There was no significant difference in
clinical or pathological stage distribution between these two sets of
esophageal cancers because locally advanced tumors (Stage II or
III) are major targets of both chemoradiotherapy and surgery [8–
10]. Sixty of the 66 surgical samples (90.9%) and 29 of the 35
biopsy samples (82.9%) appeared in a (left) and b (right) sample
cluster, respectively (Figure 1A). To investigate the number of
differentially expressed genes between these two kinds of samples
with reproducibility, we compared expression profiles among three
independent sample sets (A, B, and C): another 20 biopsy sample
set versus three surgical sample sets (A, B, and C) containing 20
randomly selected cases from the 66 cases (Figure 1B, upper). The
number of differentially expressed genes selected by u-test
(p,0.01) were 2, 295, 2,328, and 2, 245 in sets A, B, and C,
respectively. Among these 3 sets, 1,495 genes (65.1% in A, 64.2%
in B, and 66.6% in C) were commonly identified (Figure 1B,
upper). Therefore, more than 20% (1,495/6,000, 24.9%) of the
genes were differentially expressed between biopsy and surgical
samples because the average number of detectable genes in each
case was approximately 6,000. These results suggested that a large
difference exists between the biopsy and surgical samples.
From the 1,495 genes, we further selected differentially
expressed genes among the 3 sets that had a 3-fold change
between two average signal intensities of each gene between the
biopsy and surgical samples. From sets A, B, and C, 297, 273, and
300 genes were identified, respectively (Figure 1B, lower). More
than 80% of these genes were over-expressed in the surgical
samples, suggesting a preferential presence of artificial factors or a
contamination of normal portions.
To address the rationale for the difference, we finally selected
genes that expressed preferentially in all the 35 biopsy or 66
surgical samples under stringent conditions with u-test (p,0.01),
permutation test, and a 2-fold change, etc. (Materials and
Methods). By this procedure, 38 and 219 genes were identified
as up-regulated genes in the biopsy and surgical samples,
respectively (Table S1 and Figure 1C). Interestingly, in the
surgical samples, many EMT markers were found to be expressed
preferentially and frequently. Microarray results of 13 represen-
tative EMT markers including fibronectin (FN), vimentin (VIM)
and collagens (COLs) are shown in Figure 2A. Moreover,
membrane signal transducers such as cytokine, chemokine, and
receptors were also found to be up-regulated in the surgical
samples. Representative microarray and RT-PCR results of IL8,
CXCR4, CXCL9, PDGFRB, CCL5, and TLR2, respectively are
shown in Figures 2B and 2C. In correspondence with EMT, E-
cadherin (CDH1) was found to be down-regulated in the surgical
samples (Figure 2A, right lowest).
Comparison of Expression Profiles between Biopsy
Samples and Surgical Resected Esophageal Tumor
Samples Obtained from Identical Cases
In the same above way, we compared gene expression profiles
between 18 biopsy and 18 surgically resected esophageal tumor
samples, and selected 41 and 716 genes that were identified as up-
regulated genes in the two kinds of samples, respectively (Table S2
and Figure 3). In accordance with the above results from different
cases, many EMT markers and membrane signal transducers were
also found to be up-regulated frequently in the surgical samples
(Figure 4A). More importantly, two EMT regulators, ZEB1 and
ZEB2, and some EMT-related myogenic transcription factors
including MEOX2 and MEF2C were able to be selected as up-
regulated genes in the surgical samples (Figures 4A). Quantitative
real-time RT-PCR confirmed over-expression of ZEB1, ZEB2, FN,
and VIM in the 18 surgical samples of identical cases (Figure 4B).
The over-expression of ZEB1 and ZEB2 was also found in the 66
surgical samples of different cases (Figure S2), although these two
EMT regulators could not be extracted from expression profiles
under the above stringent conditions. SNAI1/Snail, SNAI2/Slug,
ZEB1/ZFHX1A, ZEB2/SIP1/ZFHX1B, TWIST1/TWIST, and
TWIST2 are representative EMT regulators [11, 12]. Among
them, TWIST1 as well as two ZEBs were over-expressed in the two
sets of esophageal tumors (Figure S3). To investigate whether
aiEMT in the mRNA levels affects immunohistochemistry (IHC),
we performed IHC on a typical mesenchymal marker vimentin in
biopsy and surgical samples of identical cases. First we determined
conditions under which normal epithelial cell layers could not be
stained, but tumor cells with EMT could be (Figures 5A, 5B),
because undifferentiated layers (basal and parabasal) have been
reported to express EMT-related genes including VIM [4]. In 3
out of 5 pairs of the samples examined, tumor lesions of a surgical
sample were found to be stained more highly than those of a
biopsy sample (Figures 5C–H); however, the remaining 2 pairs did
not show such difference (data not shown). Therefore, the aiEMT
that occurred in the surgical samples in the mRNA level was
thought to affect only a subset of surgical samples in the level of
EMT-related proteins.
Over-expression of ZEB1, ZEB2, and TWIST1 in Surgically
Resected Normal Tissues
We obtained 4 biopsy samples and 5 surgical samples of non-
cancerous tissues, and compared their expression profiles. In the
same manner with the above expression profiles of tumor tissues
(Figures 2, 4, S2, and S3), three EMT regulators (ZEB1, ZEB2,
and TWIST1) and two typical EMT markers (VIM and FN) were
found to be over-expressed in the 5 surgical samples (Figure 6A).
Our previous report showing the involvement of ZEB2 and
TWIST1 in the EMT of normal and malignant esophageal
epithelial cells [9] supports the presence there of artificially
induced EMT.
Finally, to investigate whether these 5 genes are induced in
epithelial cells by surgical resection-related ischemia, we resected a
mouse esophagus, and placed it on PBS for 0 or 4 hours, and
immediately made frozen sections followed by laser-captured
microdissection of the epithelial cell layers (Figure 6B, upper).
Expression profiles of the mouse epithelial cell layers at 0 or
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Fn were induced 4 hours after resection (Figure 6B, lower).
Quantitative real-time RT-PCR confirmed over-expression of
Zeb1, Zeb2, Vim, and Fn after resection (Figure 6C). Since overall
sensitivity of mouse affymetrix arrays is known to be lower than in
humans, and the use of a small amount of RNA such as laser-
captured subjects is also known to reduce microarray sensitivity,
Twist1 mRNA itself could not be detected in this mouse
experiment (data not shown).
To investigate whether aiEMT in the mRNA levels affects IHC,
we performed IHC on a typical mesenchymal marker vimentin
8 hours after resection. Here we determined conditions under
which normal epithelial cell layers are stained. In all of the 3
independent samples examined, normal epithelial cell layers were
not found to be stained highly 8 hours after resection (Figures 7A–
C). The discrepancy between the mRNA level and protein level
can be explained by the two following reasons: 1) although
undifferentiated layers (basal and parabasal) have been reported to
express EMT-related genes including VIM [4], their expression
levels were much lower than tumor (Figure 5B). 2) it may also be
difficult to show the approximate 2-fold change in the mRNA level
(Figures 6B, C) as in the protein level by IHC, because IHC is
inferior to RT-PCR in both sensitivity and quantification.
All of the results suggest that EMT, especially in the mRNA
level, is induced artificially in both normal and malignant
epithelial cells by surgical resection-related events (ischemia-
induced hypoxia and hyponutrition, and hypoxia-induced inflam-
mation, etc.).
Artificially Induced EMT (aiEMT) by Surgical Resection
Prevents Microarray-based Subgroup Identification
Identification of clinically significant subgroups is very impor-
tant for personalized medicine and for drug development against
intractable cases. When we used the expression profiles of the 35
biopsy samples obtained from patients treated by chemoradiother-
apy [8], unsupervised clustering with 5,570 processed genes
(Materials and Methods) identified a good responder group
consisting of 9 patients (7/9, 78% showing complete response to
chemoradiotherapy) from the 35 (Figure 8A, left). However, when
the profiles of the 66 surgical samples were used, unsupervised
clustering with 2,016 processed genes could not identify any
subgroup (Figure 8A, right). Thus, biopsy sample expression
profiles seemed to be more effective in subgroup identification
than those of the surgical samples. In fact, we previously reported
that biopsy sample expression profiles could distinguish long-term
or short-term survivors by definitive chemoradiotherapy [8];
however, surgical sample expression profiles never identified poor
prognostic subgroups with extensive lymph node metastasis [10].
Moreover, in the surgical samples, EMT was accelerated in 36
(85.7%) out of 42 esophageal cancers [9]. This high percentage
seems to be caused by aiEMT.
To address the reason why subgrouping is difficult in surgical
samples, we compared the number and distribution of each of the
processed genes, which were used for unsupervised clustering. We
first selected genes with a signal intensity of more than 1,000 in
more than 10% of the samples. From 35 biopsy and 66 surgical
samples, 6,551 and 4,797 genes, respectively, were selected. From
these genes, we finally selected more than 3-fold changed genes by
comparing the average signal intensity of each gene in more than
10% of the samples. In the 35 biopsy samples, 85% (5,570) of
6,551 first processed genes remained, whereas the number of final
processed genes decreased from 4,797 first processed genes to
2,016 (42%) (Figure 8B, upper). Of the 2,016 finally processed
genes in the surgical samples, 1,724 (86%) were included in the
5,570 finally processed genes in the biopsy samples; however,
3,846 (69%) of 5,570 genes were unique to the biopsy samples
(Figure 8B, lower). Moreover, frequency distribution (for percent-
age of samples) of these two finally processed-gene sets shows that
approximately 60% of the 2,016 processed genes in the surgical
samples express in only a limited number of cases (0–10%)
(Figure 8C). Accordingly, aiEMT in surgical samples may
diminish the number of processed genes useful for subgroup
identification.
Discussion
We recently reported the presence of crosstalk between
Hedgehog (Hh) and EMT signaling in normal and malignant
epithelial cells of the esophagus [9]. In that report, ZEB2 was
shown to be a downstream gene of both a primary transcriptional
transducer GLI1 in Hh signaling and of another EMT regulator,
TWIST1, and that ZEB2 further up-regulated 5 chemokine or
growth factor receptors, PDGFRA, EDNRA, CXCR4, VEGFR2, and
TRKB (Figure S4). The Hh signal block inhibited esophageal
keratinocyte differentiation and cancer cell invasion and growth.
Accordingly, over-expression of ZEB2 and TWIST1 in surgical
samples of both normal and tumor tissues can induce EMT,
resulting in over-expression of representative EMT markers VIM,
FN, and COLs (Figures 2, 4, 6, S2, and S3) and membrane signal
transducers IL8, CXCL4, CCL5, CXCR4, PDGFRB, and TLR2
(Figure 2). Over-expression of the membrane signal transducers
can activate further down-stream cascades. This is a major reason
for the large difference of expression profiles between biopsy and
surgical samples (Figures 1 and 3).
Extensive contamination of normal mesenchymal portions in
surgically resected tumor tissues can also explain the over-
expression of those EMT regulators and EMT-related genes, even
though trained pathologists carefully excised bulk tissue samples
from the main tumor, leaving a clear margin from the surrounding
normal tissue (Materials and Methods). However, the over-
expression was also observed in surgically resected normal tissue
and mouse epithelial cell layers 4 hours after resection (Figure 6).
Therefore, we concluded that artificially induced EMT, termed
aiEMT, occurred in both normal and malignant epithelial cells by
the surgical resection-related events (ischemia-induced hypoxia,
ischemia-induced hyponutrition, and hypoxia-induced inflamma-
tion, etc.) (Figure S1).
Recently, the hypoxia-inducible factors (HIF-1A or HIF-2A)
have been reported to directly regulate TWIST1 [13, 14] and
Figure 1. Comparison of expression profiles between biopsy and surgically resected esophageal tumor samples obtained from
different cases. (A) Unsupervised clustering with 3,126 processed genes. Surgical (a) and biopsy sample clusters (b) are shown. (B) Comparison of
expression profiles among three independent sets (A, B, and C): a randomly selected 20-biopsy sample set versus three surgical sample sets (A, B, and
C) containing 20 independent cases. The number of differentially expressed genes selected by u-test (p,0.01): 2, 295 in set A, 2,328 in set B, and 2,
245 in set C (Upper). The number of differentially expressed genes with a 3-fold change between two average signal intensities: 297, 273, and 300.
Clustering results with these gene sets (Lower). (C) Up-regulated genes in surgical or biopsy samples. By the use of all of the profiles under stringent
selection conditions (see Materials and Methods), 38 and 219 genes were identified as up-regulated genes in the biopsy and surgical samples,
respectively.
doi:10.1371/journal.pone.0018196.g001
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SNAIL, through physical interaction on the SLUG domain and
Snail’s lysine residues K98 and K137 [15]. The SNAI1 binding
site was also found in the 5’ promoter region of ZEB2 [16]. Over-
expression of both HIF1A and LOXL2 was observed only in the
surgically resected tumor tissues obtained from different cases
(Figure S5). Moreover, other HIF1 families (HIF1B and HIF2A)
were never over-expressed in any of the surgical samples.
Therefore, elucidation of the molecular mechanisms of aiEMT
in surgical samples remains for future studies. However, we noted
that ischemia-induced hypoxia and/or inflammation has been
reported to release repression of NFkB [17], which regulates
ZEB1, ZEB2, and TWIST1 [18, 19] and that TGF-b signaling
may be involved in aiEMT, because over-expression of NFKB1
and TGFBR2 was found in surgical samples (Figure S6).
As mentioned in the Introduction, surgical samples have been
used as important subjects for clinical and basic cancer research for
many years. Therefore, aiEMT in surgical samples may have
possibly interfered with or prevented not only microarray- or
immunohistochemistry-based clinical research (diagnostic marker
Figure 2. Representative EMT related genes over-expressed in surgically resected esophageal tumor samples. (A) Expression patterns
of an epithelial cell marker E-cadherin (CDH1) and typical EMT markers including fibronectin (FN), vimentin (VIM), and collagens (COLs). (B) Expression
patterns of 6 membrane signal transducers: a cytokine (IL8), two chemokines (CXCL9 and CCL5), and three membrane type receptors (CXCR4, PDGFRB,
and TLR2). (C) Semi-quantitative RT-PCR results of these 6 membrane transducers in representative samples.
doi:10.1371/journal.pone.0018196.g002
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evaluation, etc.) but also basic research (making a signal pathway
map, therapeutic target identification, etc.). This study will likely
evoke fundamental misinterpretation including underestimation of
the prognostic evaluation power of markers by overestimation of
EMT in past cancer research, and will provide some advice for the
near future as follows: 1) Understanding how long the tissues were
underanischemiccondition(fromstartofresectiontostockorRNA
preparation). The total amount of time should never exceed
4 hours. 2) Prevalence of biopsy samples for in vivo expression
profiling with low biases on basic and clinical research; for example,
for clinical outcome prediction of not only neoadjuvant but also
adjuvant chemotherapy, radiotherapy, and chemoradiotherapy
such as in previous reports [8, 20–23]. 3) Checking cancer cell
contents and normal- or necrotic-tissue contamination in biopsy
samples for the prevalence. In sampling by a needle biopsy, tumor
portions (2mm X 2mm) should be obtained from a margin
(periphery) of the tumor by exclusion of central necrotic lesions
under endoscopy. If necrotic lesions were severely contaminated in
the samples, those samples should be excluded by quantifying and
qualifying RNA. If the samples contained extensive normal lesions,
such samples can be excluded by the expression profile-based
scoring method using normal and/or tumor specific genes.
Materials and Methods
Tissue Samples
All esophageal cancer (squamous cell carcinomas) and non-
cancerous tissues were provided by the Central Hospital or East
Hospital at the National Cancer Center after obtaining written
informed consent from each patient and approval by the Center’s
Ethics Committee.
All surgical samples were obtained from patients without
neoadjuvant therapy, and all biopsy samples were obtained before
treatment. For the surgical samples, trained pathologists carefully
excised bulk tissue samples from the main tumor, leaving a clear
Figure 3. Up-regulated genes in biopsy and surgically resected esophageal tumor samples obtained from identical cases. By
stringent selection (see Materials and Methods), 41 and 716 genes were identified as up-regulated genes in the biopsy and surgical samples,
respectively.
doi:10.1371/journal.pone.0018196.g003
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surgical samples from a margin (periphery) of the tumor. For the
needle biopsy samples, tumor portions (2 mm X 2 mm) were
obtained under endoscopy from a margin of the tumor by
exclusion of any central necrotic lesions. If the samples were
severely contaminated by necrotic lesions, those samples were
excluded by quantifying and qualifying RNA. If the samples
contained extensive normal lesions, we excluded such samples by
Figure 4. Representative EMT related genes also over-expressed in surgically resected esophageal tumor samples obtained from
identical cases. (A) Expression patterns of 2 representative EMT regulators (ZEB1 and ZEB2), 8 typical EMT markers including fibronectin (FN),
vimentin (VIM), 3 collagens (COL1A2, COL3A1, and COL14A1), FBN1, MYH11, and ACTC1, and 2 EMT-related myogenic transcription factors (MEOX2 and
MEF2C). (B) Quantitative real-time RT-PCR results of ZEB1, ZEB2, FN, and VIM. Closed box: surgical sample; Open box: biopsy sample.
doi:10.1371/journal.pone.0018196.g004
Figure 5. Immunohistochemistry (IHC) of a typical EMT marker vimentin in biopsy and surgically resected tissues. IHC of vimentin in
an additional surgical sample, which contained normal portions, showed that normal esophageal epithelial cells were not stained, but invasive tumor
cells were (A, B). In 3 out of 5 pairs of biopsy and surgical samples, over-expression of vimentin was observed in the surgical samples (biopsy: C, E, G;
surgical: D, F, H).
doi:10.1371/journal.pone.0018196.g005
Artificial EMT in Samples
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tumor specific genes (in preparation).
The overall process of an esophageal cancer operation requires
much time. Therefore, surgical samples were excised from a
margin of the tumor by trained pathologists after exposure for 4–
7 hours under an ischemic condition, and were immediately
frozen at 280uC until use. On the contrary, needle biopsy samples
resected under endoscopy were immediately frozen at 280uC until
use. Clinicopathological information is given in Tables S3, S4, S5.
Laser Microdissection followed by RNA Extraction and
Amplification
Cryostat sections (8mm) of frozen mouse esophageal samples were
laser-microdissected with the mmi CellCut system (MMI Inc.,
Rockledge, FL). Total RNA was isolated by suspending the cells in
an ISOGEN lysis buffer (Nippon Gene, Toyama, Japan) followed by
precipitation with isopropanol. RNA was amplified by an efficient
method of high-fidelity mRNA amplification, called TALPAT (T7
RNA polymerase promoter-attached, adaptor ligation-mediated, and
PCR amplification followed by in vitro T7-transcription) [24–28].
Microarray Analysis
Gene expression profiles were obtained from 166 samples:
tumor sets (different cases) of independent 35 and 20 biopsy
samples and 66 surgical samples, another tumor set (identical case)
of 18 biopsy samples and 18 surgical samples, a normal set of 4
biopsy samples and 5 surgical samples. Total RNAs extracted from
the bulk tissue samples were biotin-labeled and hybridized to high-
Figure 6. Over-expression of EMT regulators and markers in surgically resected normal tissues. (A) Over-expression of EMT-regulators
(ZEB1, ZEB2, and TWIST1) and EMT-markers (VIM and FN) in surgically resected normal esophagus mucosa. (B) Induction of mouse Zeb1, Zeb2, Vim, and
Fn under ischemic condition. After resection of mouse esophagus, we placed it on PBS for 0 or 4 hours at room temperature (under an ischemic
condition), immediately made frozen sections, captured the epithelial cell layer (upper) by laser microdissection, amplified mRNA by TALPAT [24–28],
and obtained expression profiles using Mouse Expression Array 430 2.0 (Affymetrix, Santa Clara, CA). Experiments were performed on 3 mice. The
Zeb1, Zeb2, Vim, and Fn genes are induced 4 hours after resection (Lower). *P,0.05. (C) Quantitative real time RT-PCR of Zeb1, Zeb2, Vim, and Fn.
Over-expression of Zeb1, Zeb2, Vim, and Fn, shown by microarray, was confirmed.
doi:10.1371/journal.pone.0018196.g006
Figure 7. Immunohistochemistry (IHC) of a typical EMT marker vimentin in mouse esophagus. After resection of mouse esophagus, we
placed it on PBS for 0, 4, 8 hours at room temperature (under an ischemic condition), immediately made frozen sections, and IHC of vimentin was
performed under more sensitive conditions compared with Figure 5. Experiments were performed on 3 mice (A–C). Over-expression of vimentin in
mouse esophageal epithelium was not observed even after 8 hours of exposure under an ischemic condition. Arrow: vimentin-positive smooth
muscle, arrow head: mouse stratified esophageal epithelial cell layers.
doi:10.1371/journal.pone.0018196.g007
Artificial EMT in Samples
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U133PLUS2.0 Array, Affymetrix, Santa Clara, CA, USA) in
accordance with the manufacturer’s instructions. For laser-
captured mouse esophageal epithelial cell layers, Mouse Genome
430 2.0 Array was used. The scanned data of the arrays were
processed by Affymetrix Microarray Suite version 4.0 or 5.0,
which scaled the average intensity of all the genes on each array to
a target signal of 1,000 to reliably compare variable multiple
arrays. All the microarray data have been deposited in a MIAME
compliant database, GEO; the accession number SuperSeries
GSE22954.
Gene Selection from Microarray Data and Hierarchical
Clustering
Hierarchical clustering is widely used as one of the unsupervised
learning methods. Hierarchical clustering of microarray data was
performed by the use of GeneSpring (Agilent Technologies Ltd.,
CA, USA), Microsoft EXCEL, and Cluster & TreeView software
[29].For unsupervised clustering (Figures 1A and 8A), we first
selected genes with a signal intensity of more than 1,000 in more
than 10% of the samples, and from these genes, we finally selected
more than 3-fold changed genes by comparing the average signal
intensity of each gene in more than 10% of the samples. For
overexpressed genes in the surgical or biopsy samples, we first
selected genes by u-test (p,0.01), permutation test, and 2- or 3-
fold change between the average signal intensities of the two sets of
samples, and from the first selected genes we finally selected genes
with more than 1,000 in average signal intensity.
Semi-quantitative and Quantitative RT-PCR
Total RNA was isolated by suspending the cells in Isogen lysis
buffer (Nippon Gene, Toyama, Japan) followed by precipitation
with isopropanol. RT-PCR was carried out using primer sets
designed for detecting the 39 side of cDNA of each human gene:
for IL8,5 9- TGCCAAGGAGTGCTAAAG -39 and 59- CTCCA-
CAACCCTCTGCAC-39, for CXCR4,5 9-TGTATGTCTCG-
TGGTAGGAC-39 and 59-AGACTGTACACTGTAGGTGC-
39, for CXCL9, 59-ACAAAGAAAATATTTCAAATTACAA-
GG-39 and 59-GGGAACGGTGAAGTACTAAGC-39, for
PDGFRB,5 9-ACTGCCCAGACCTAGCAGTG-39 and 59-CAG-
GGAAGTAAGGTGCCAAC-39, for CCL5, 59-CCCCGTG-
CCCACATCAAGGAGTATTT-39 and 59-CGTCCAGCCTG-
GGGAAGGTTTTTGTA-39, for TLR2,5 9-CCAGCAGGAA-
CATCTGCTAT-39 and 59-TCCAGGTAGGTCTTGGTGTT-
39, for ZEB1,5 9-CGTCTCTTTCAGCATCACCA-39 and 59-
ATGGGAGACACCAAACCAAC-39, for ZEB2,5 9-CAT-
GACGTTGATCATTTGGGC-39 and 59-CGAGCATGGT-
CATTTTCAAAAG-39, for FN, 59-CGGGGGAAATAATTC-
CTGTG-39 and 59-CCTTGCAGGCAATCTCTTTG-39, for
VIM, 59-GCTTTCAAGTGCCTTTCTGC-39 and 59-GTTG-
GTTGGATACTTGCTGG-39, and for ACTB (b-actin), 59-
TCATCACCATTGGCAATGAG-39 and 59-CACTGTGTT-
GGCGTACAGGT-39. Primer sets for detecting each mouse gene
were also designed: for Zeb1, 59-TAACATTTATACTTGC-
CTCC-39 and 59-GCTAAGGGAATGAGTTATGG-39, for
Zeb2, 59-ACCAAATCAGACCACGAGGA-39 and 59-GCCCCT-
TCTGTCCCTCTCTA-39, for Fn, 59-CCGTGGGATGTTTT
GAGACT-39 and 59-GGCAAAAGAAAGCAGAGGTG-39, for
Vim,5 9-ACGGTTGAGACCAGAGATGG-39 and 59-CGTCTT-
TTGGGGTGTCAGTT-39 , and for ActB, 59-GCTCTTTTCC-
AGCCTTCCTT-39 and 59-GTACTTGCGCTCAGGAGGAG-
39. For semi-quantitative RT-PCR, we showed data within linear
range by performing 25–35 cycles of PCR. Quantitative real-time
PCR was performed by a Bio-Rad iCycler with iQ Syber Green
Supermix (Bio-Rad, Hercules, CA, USA) as directed by the
manufacturer. The value of 1/2N (N: the number of PCR cycles
corresponding to the onset of the linear amplification of each gene
product) was calculated as a relative mRNA expression level of
each gene normalized to ACTB. The data from 2 independent
analyses for each sample were averaged.
Immunohistochemistry
For immunohistochemical staining of frozen sections of human
and murine esophagus, specimens that were embedded in a
TissueTek OCT medium (VWR Scientific Products, West
Chester, CA) and stocked at 280uC until use were cut into 8mm
sections, which were then left for 30 min at room temperature
followed by fixing in 4% paraformaldehyde for 20 min at room
temperature. Endogenous peroxidase activity was inhibited with
3% H2O2 in methanol for 30 min. Blocking was carried out with
Vectastain ABC Elite Kit (Vector Laboratories, Burlingame, CA)
for 30 min at room temperature. Sections were incubated for
60 min at room temperature with diluted mouse monoclonal
antibody directed against human vimentin (N1521, DAKO,
Carpinteria, CA) or rabbit polyclonal antibody directed against
mouse vimentin (#3932, Cell Signaling Technology Japan,
Tokyo, Japan). After washing sections with PBS, biotinylated
secondary antibodies were applied for 30 min at room tempera-
ture. Detection was carried out by using Vectastain ABC Elite Kit
(Vector Laboratories) and the DAB system (DAKO, Tokyo), and
the sections were counter-stained with 1% Methyl Green. (Sigma,
Saint Luis, MO)
Supporting Information
Figure S1 Schema of artificial factors during surgical resection
and sample transportation. Biopsy samples are small, much
fresher, with low contamination of normal portions compared to
surgical samples, whereas some artificial factors such as ischemia,
hypoxia, hyponutrition, and cold stress possibly occur during
surgical resection and sample transportation.
(TIF)
Figure S2 Expression levels of ZEB1 and ZEB2 in two sets of
biopsy and surgical samples (different and identical cases). Over-
expression of both genes is observed in surgically resected
esophageal tumors, except ZEB2 in the different cases. *P,0.05.
(TIF)
Figure S3 Expression levels of TWIST1 in two sets of biopsy and
surgical samples (different and identical cases). Over-expression of
TWIST1 is observed in surgically resected esophageal tumors.
*P,0.05.
(TIF)
Figure 8. Artificially induced EMT prevents microarray-based subgroup identification. (A) Unsupervised clustering of 35 biopsy and 66
surgically resected esophageal tumor samples with 5,570 and 2,016 processed genes, respectively. A sample cluster with 2,971 genes appears only in
the biopsy samples. (B) Comparison of the number of processed genes for unsupervised clustering between biopsy and surgical samples. The
number of processed genes and commonly selected genes is indicated. (C) Frequency distribution for percentage of samples of finally processed-
gene sets. Each distribution of 5, 570 genes in biopsy samples (Left) and 2,016 genes in surgical samples (Right) is indicated.
doi:10.1371/journal.pone.0018196.g008
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PLoS ONE | www.plosone.org 12 April 2011 | Volume 6 | Issue 4 | e18196Figure S4 Schema of crosstalk between Hh and EMT signal
pathways in esophageal cancers. The primary transcriptional factor
GLI1 and an EMT regulator TWIST1 regulate another EMT
regulatorZEB2, whichactivatesanygene includingmembranetype
receptors (PDGFRA, EDNRA, CXCR4, VEGFR2,a n dTRKB) [9].
(TIF)
Figure S5 Expression levels of HIF1A, HIF1B, HIF2A,a n dLOXL2
in two sets of biopsy and surgical samples (different and identical
cases). Over-expression of HIF1A and its target LOXL2 is observed
only in surgically resected esophageal tumors (different cases).
(TIF)
Figure S6 Expression levels of NFKB1 and TGFBR2 in two sets of
biopsy and surgically resected tumorsamples(different and identical
cases) and in biopsy and surgically resected non-cancerous tissues
(normal). Over-expression of NFKB1 and TGFBR2 is observed in all
the sets of surgically resected samples. *P,0.05.
(TIF)
Table S1 219 up-regulated genes in 66 surgically resected
esophageal tumors.
(DOC)
Table S2 716 up-regulated genes in 18 surgically resected
esophageal tumors.
(DOC)
Table S3 Clinicopathological information of biopsy samples
from different cases with esophageal squamous cell carcinoma.
(DOC)
Table S4 Clinicopathological information of surgical samples
from different cases with esophageal squamous cell carcinoma.
(DOC)
Table S5 Clinicopathological information of biopsy and surgical
samples from different cases with esophageal squamous cell
carcinoma.
(DOC)
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